Disposable manufacturing tech

iStock/CharlieAJA

Amgen confirms it is working on a version of Alexion's drug

Amgen developing Soliris biosimilar

By Gareth Macdonald

Amgen has started a trial of a biosimilar version of Alexion Pharmaceuticals’ Soliris (Eculizumab).